Pulmonary Perfusion with Oxygenated Blood or Custodiol HTK Solution during Cardiac Surgery for Postoperative Pulmonary Function in COPD Patients
The Pulmonary Protection Trial (PP-Trial) randomizes 90 patients undergoing CPB-dependent cardiac surgery to evaluate whether pulmonary perfusion with oxygenated blood or custodiol HTK solution reduces postoperative pulmonary dysfunction in COPD patients.
